Literature DB >> 14762190

The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs.

Michelle M Mello1, David M Studdert, Troyen A Brennan.   

Abstract

Keywords:  Health Care and Public Health; Legal Approach

Mesh：

Year:  2004        PMID： 14762190     DOI： 10.1056/NEJMlim035683

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics.

Authors:  William B Vogt; Geoffrey Joyce; Jing Xia; Riad Dirani; George Wan; Dana P Goldman
Journal:  Health Aff (Millwood)       Date:  2011-12       Impact factor: 6.301

2.  Impact of two Medicaid prior-authorization policies on antihypertensive use and costs among Michigan and Indiana residents dually enrolled in Medicaid and Medicare: results of a longitudinal, population-based study.

Authors:  Michael R Law; Christine Y Lu; Stephen B Soumerai; Amy Johnson Graves; Robert F LeCates; Fang Zhang; Dennis Ross-Degnan; Alyce S Adams
Journal:  Clin Ther       Date:  2010-04       Impact factor: 3.393

3.  State appellant cases for testicular torsion: Case review from 1985 to 2015.

Authors:  Thomas W Gaither; Hillary L Copp
Journal:  J Pediatr Urol       Date:  2016-04-20       Impact factor: 1.830

4.  Prior authorization for biologic disease-modifying antirheumatic drugs: a description of US Medicaid programs.

Authors:  Michael A Fischer; Jennifer M Polinski; Amber D Servi; Jessica Agnew-Blais; Liljana Kaci; Daniel H Solomon
Journal:  Arthritis Rheum       Date:  2008-11-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.